Why Fluorine-18 and Gallium-68 Are Leading Radioisotopes in Radiopharmaceutical Theranostics
The global radiopharmaceutical theranostics market is growing as healthcare providers and research institutions invest in advanced radioisotopes to support diagnostic imaging and targeted therapy applications. The market was valued at USD 2.11 billion in 2024 and is projected to reach USD 4.374 billion by 2035, growing at a CAGR of 6.85%. The Radiopharmaceutical Theranostics Market includes...
0 Comments 0 Shares 41 Views